Why INDICAID healthTM ?
INDICAID health collaborates with healthcare institutions and senior care facilities to offer patients and staff at-home diagnostic tests manufactured in the USA. These tests are complemented by our in-house CLIA-certified lab, along with integrated virtual care choices and treatments, empowering patients to positively impact their health at their preferred time and place. INDICAID health facilitates an enhanced patient experience, promotes health equity and accessibility, while simultaneously driving revenue growth and optimizing staff productivity.
Embrace the Growing At-Home Health Market
The at-home diagnostics market is expected to grow to $8.5 Billion by 2030.¹The US home healthcare market is projected to grow to $278 billion by 2032.²
FOR HEALTHCARE PROVIDERS
Hospitals, Clinics, Physician Groups and Urgent Care Centers like yours need to balance improving patient experience and outcomes with managing costs and efficiency.
INDICAID health helps you by:
Improving healthcare access and outcomes
Delivering preventative health insights
Boosting staff productivity
Generating cash-based revenue
FOR SENIOR CARE PROVIDERS
Long Term Care, Assisted Living, Skilled Nursing Facilities, and Retirement Communities
Infections present a major health concern for older adults, encompassing respiratory infections, sexually transmitted infections, women's health-related infections, and others. The risk of severe illness from any infection, compounded by its potential interaction with existing health issues, increases with age.
Get the facts:
• Rates of STIs like gonorrhea and chlamydia have more than doubled in older adults. 3• Up to 4.8 million/year RSV incidents are expected to occur in adults over age 60. 4
INDICAID health helps organizations like yours to:
Keep
residents and
patients
safer
Mitigate the chance
of infection
for administrators
and caregivers
Speed up
the recovery time
for staff
and patients
1 - Vision Research, 2022
2 - Precedence Research, 2022
3 - AARP, 2021
4 - Clinical Infectious Diseases, 2023